Biologic and Epidemiologic Markers of Endometriosis (BEME)

Condition: Endometriosis, fibroids, polyps

Eligibility

Inclusion Criteria

  • 18-60 years old
  • Laparoscopy for conditions including endometriosis, fibrioids, polyps pelvic pain and/or infertility

Exclusion Criteria

  • Suspected pregnancy or malignancy

Full Study Name

Biologic and Epidemiologic Markers of Endometriosis (BEME) (IRB no. 0063)

Summary

The purpose of this study is to identify biomarkers of benign gynecologic conditions, with a particular focus on endometriosis. In endometriosis, uterus-like tissue grows in other parts of the body. Biomarkers are molecules found in blood, body fluids, and tissues that can be a sign of a normal or abnormal process of a disease.

Endometriosis is difficult to diagnosis because symptoms are non-specific and varied; some women may not even show symptoms. The study aims to understand patient lifestyle factors, outcomes and experiences of pain and infertility associated with the disease. In so doing, researchers hope to develop novel ways to diagnose endometriosis without the need for surgery.

Participants will be asked to complete questionnaires about their reproductive health and history. Researchers will also collect biological specimens (such as tissue and blood), and medical records will be reviewed.


Principal Investigator

Kate Lawrenson, MD

Co-Investigators

Matthew Siedhoff, MD
Mireille Truong, MD
Kelly Wright, MD

Contact